Defunct Company
Total Trials
15
As Lead Sponsor
13
As Collaborator
2
Total Enrollment
1,235
NCT00761436
Pilot Study of Safety and Efficacy of Spheramine
Phase: Phase 2
Role: Collaborator
Start: Feb 29, 2000
Completion: May 14, 2012
NCT00050687
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 30, 2001
Completion: Mar 31, 2005
NCT00206687
STEPS Trial - Spheramine Safety and Efficacy Study
Start: Jan 8, 2003
NCT00073385
Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer
Start: Sep 30, 2003
Completion: Oct 31, 2004
NCT00087477
A Pilot Study of Pivanex in Patients With Malignant Melanoma
Start: Jan 31, 2004
Completion: Aug 31, 2004
NCT00083473
A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia
Start: May 31, 2004
Completion: Apr 30, 2005
NCT00103519
Study of DITPA in Patients With Congestive Heart Failure
Start: Dec 31, 2004
Completion: Dec 31, 2006
NCT00447564
Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
Phase: Phase 3
Start: Oct 31, 2006
Completion: Jul 31, 2008
NCT00630201
Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
Start: Oct 31, 2007
Completion: Feb 28, 2009
NCT00768482
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
Start: Sep 30, 2008
Completion: Dec 31, 2008
NCT00772785
Study of Probuphine in Patients With Opioid Dependence
NCT01114308
A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
Start: Apr 30, 2010
Completion: May 31, 2011
NCT01262261
Re-Treatment Study of Probuphine in Opioid Addiction
Start: Nov 30, 2010
Completion: Nov 30, 2011
NCT02180659
A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants
Start: Jul 31, 2014
Completion: May 31, 2015
NCT03250117
Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
Start: Oct 10, 2017
Completion: May 22, 2018